Gene delivery of a mutant TGFΒ3 reduces markers of scar tissue formation after cutaneous wounding

Molecular Therapy

Volumn 18, Issue 12, 2010, Pages 2104-2111

  Waddington, Simon N ^a   Crossley, Rachel ^b   Sheard, Vicky ^b   Howe, Steven J ^c   Buckley, Suzanne M K ^a   Coughlan, Lynda ^d   Gilham, David E ^b   Hawkins, Robert E ^b   McKay, Tristan R ^b,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LATENCY ASSOCIATED PEPTIDE; LENTIVIRUS VECTOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL MIGRATION; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; EPITHELIZATION; FIBROBLAST; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SCAR FORMATION; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SKIN INJURY; VIRAL GENE DELIVERY SYSTEM; WOUND HEALING;

EID: 78650868813     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.174     Document Type: Article

References (50)

1. Lee, JA, Conejero, JA, Mason, JM, Parrett, BM, Wear-Maggitti, KD, Grant, RT et al. (2005). Lentiviral transfection with the PDGF-B gene improves diabetic wound healing. Plast Reconstr Surg 116: 532-538.
2. Stoff, A, Rivera, AA, Mathis, JM, Moore, ST, Banerjee, NS, Everts, M et al. (2007). Effect of adenoviral mediated overexpression of fbromodulin on human dermal fbroblasts and scar formation in full-thickness incisional wounds. J Mol Med 85: 481-496.
3. Tyrone, JW, Mogford, JE, Chandler, LA, Ma, C, Xia, Y, Pierce, GF et al. (2000). Collagen-embedded platelet-derived growth factor DNA plasmid promotes wound healing in a dermal ulcer model. J Surg Res 93: 230-236.
4. Massagué, J, Seoane, J and Wotton, D (2005). Smad transcription factors. Genes Dev 19: 2783-2810.
5. Woodley, DT, Remington, J, Huang, Y, Hou, Y, Li, W, Keene, DR et al. (2007). Intravenously injected human fbroblasts home to skin wounds, deliver type VII collagen, and promote wound healing. Mol Ther 15: 628-635.
6. Wu, Y, Chen, L, Scott, PG and Tredget, EE (2007). Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 25: 2648-2659.
7. Chu, Y, Guo, F, Li, Y, Li, X, Zhou, T and Guo, Y (2008). A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fbroblasts. Connect Tissue Res 49: 92-98.
8. Occleston, NL, O'Kane, S, Goldspink, N and Ferguson, MW (2008). New therapeutics for the prevention and reduction of scarring. Drug Discov Today 13: 973-981.
9. Rodgers, KE, Espinoza, T, Felix, J, Roda, N, Maldonado, S and diZerega, G (2003). Acceleration of healing, reduction of fbrotic scar, and normalization of tissue architecture by an angiotensin analogue, NorLeu3-A(1-7). Plast Reconstr Surg 111: 1195-1206.
10. Sun, W, Lin, H, Xie, H, Chen, B, Zhao, W, Han, Q et al. (2007). Collagen membranes loaded with collagen-binding human PDGF-BB accelerate wound healing in a rabbit dermal ischemic ulcer model. Growth Factors 25: 309-318.
11. Liu, W, Wang, DR and Cao, YL (2004). TGF-beta: a fbrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 4: 123-136.
12. Sadick, H, Herberger, A, Riedel, K, Bran, G, Goessler, U, Hoermann, K et al. (2008). TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fbroblasts. Int J Mol Med 22: 55-60.
13. Arany, PR, Flanders, KC, Kobayashi, T, Kuo, CK, Stuelten, C, Desai, KV et al. (2006). Smad3 defciency alters key structural elements of the extracellular matrix and mechanotransduction of wound closure. Proc Natl Acad Sci USA 103: 9250-9255.
14. Ashcroft, GS, Yang, X, Glick, AB, Weinstein, M, Letterio, JL, Mizel, DE et al. (1999). Mice lacking Smad3 show accelerated wound healing and an impaired local infammatory response. Nat Cell Biol 1: 260-266.
15. Flanders, KC (2004). Smad3 as a mediator of the fbrotic response. Int J Exp Pathol 85: 47-64.
16. Shi, Y and Massagué, J (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
17. Grinnell, F (1994). Fibroblasts, myofbroblasts, and wound contraction. J Cell Biol 124: 401-404.
18. Martin, P and Parkhurst, SM (2004). Parallels between tissue repair and embryo morphogenesis. Development 131: 3021-3034.
19. Cowin, AJ, Brosnan, MP, Holmes, TM and Ferguson, MW (1998). Endogenous infammatory response to dermal wound healing in the fetal and adult mouse. Dev Dyn 212: 385-393.
20. Whitby, DJ and Ferguson, MW (1991). The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development 112: 651-668.
21. Lu, L, Saulis, AS, Liu, WR, Roy, NK, Chao, JD, Ledbetter, S et al. (2005). The temporal effects of anti-TGF-beta1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 201: 391-397.
22. Soo, C, Beanes, SR, Hu, FY, Zhang, X, Dang, C, Chang, G et al. (2003). Ontogenetic transition in fetal wound transforming growth factor-beta regulation correlates with collagen organization. Am J Pathol 163: 2459-2476.
23. Occleston, NL, Laverty, HG, O'Kane, S and Ferguson, MW (2008). Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical. J Biomater Sci Polym Ed 19: 1047-1063.
24. Wakefeld, LM, Winokur, TS, Hollands, RS, Christopherson, K, Levinson, AD and Sporn, MB (1990). Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86: 1976-1984.
25. Annes, JP, Chen, Y, Munger, JS and Rifkin, DB (2004). Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 165: 723-734.
26. Asano, Y, Ihn, H, Jinnin, M, Mimura, Y and Tamaki, K (2006). Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fbroblasts derived from localized scleroderma. J Invest Dermatol 126: 1761-1769.
27. Asano, Y, Ihn, H, Yamane, K, Jinnin, M, Mimura, Y and Tamaki, K (2005). Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fbroblasts. J Immunol 175: 7708-7718.
28. de Felipe, P, Hughes, LE, Ryan, MD and Brown, JD (2003). Co-translational, intraribosomal cleavage of polypeptides by the foot-and-mouth disease virus 2A peptide. J Biol Chem 278: 11441-11448.
29. Szymczak, AL, Workman, CJ, Wang, Y, Vignali, KM, Dilioglou, S, Vanin, EF et al. (2004). Correction of multi-gene defciency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol 22: 589-594.
30. Dennler, S, Itoh, S, Vivien, D, ten Dijke, P, Huet, S and Gauthier, JM (1998). Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17: 3091-3100.
31. Korchynskyi, O and ten Dijke, P (2002). Identifcation and functional characterization of distinct critically important bone morphogenetic protein-specifc response elements in the Id1 promoter. J Biol Chem 277: 4883-4891.
32. Thomas, GJ, Poomsawat, S, Lewis, M P, Hart, IR, Speight, PM and Marshall, JF (2001). alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol 116: 898-904.
33. Filyak, Y, Filyak, O, Souchelnytskyi, S and Stoika, R (2008). Doxorubicin inhibits TGF-beta signaling in human lung carcinoma A549 cells. Eur J Pharmacol 590: 67-73.
34. Kaivo-Oja, N, Mottershead, DG, Mazerbourg, S, Myllymaa, S, Duprat, S, Gilchrist, RB et al. (2005). Adenoviral gene transfer allows Smad-responsive gene promoter analyses and delineation of type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells. J Clin Endocrinol Metab 90: 271-278.
35. Kopp, J, Preis, E, Said, H, Hafemann, B, Wickert, L, Gressner, AM et al. (2005). Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fbroblasts. J Biol Chem 280: 21570-21576.
36. von Bubnoff, A, Peiffer, DA, Blitz, IL, Hayata, T, Ogata, S, Zeng, Q et al. (2005). Phylogenetic footprinting and genome scanning identify vertebrate BMP response elements and new target genes. Dev Biol 281: 210-226.
37. Abe, M, Harpel, JG, Metz, CN, Nunes, I, Loskutoff, DJ and Rifkin, DB (1994). An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216: 276-284.
38. Thomas, GJ, Hart, IR, Speight, PM and Marshall, JF (2002). Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells. Br J Cancer 87: 859-867.
39. Martinez-Ferrer, M, Afshar-Sherif, AR, Uwamariya, C, de Crombrugghe, B, Davidson, JM and Bhowmick, NA (2010). Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol 176: 98-107.
40. Sorg, H, Schulz, T, Krueger, C and Vollmar, B (2009). Consequences of surgical stress on the kinetics of skin wound healing: partial hepatectomy delays and functionally alters dermal repair. Wound Repair Regen 17: 367-377.
41. Gjertsson, I, Laurie, KL, Devitt, J, Howe, SJ, Thrasher, AJ, Holmdahl, R et al. (2009). Tolerance induction using lentiviral gene delivery delays onset and severity of collagen II arthritis. Mol Ther 17: 632-640.
42. Pan, D, Gunther, R, Duan, W, Wendell, S, Kaemmerer, W, Kafri, T et al. (2002). Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Mol Ther 6: 19-29.
43. Rahim, AA, Wong, AM, Howe, SJ, Buckley, SM, Acosta-Saltos, AD, Elston, KE et al. (2009). Effcient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther 16: 509-520.
44. Apolonia, L, Waddington, SN, Fernandes, C, Ward, NJ, Bouma, G, Blundell, MP et al. (2007). Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther 15: 1947-1954.
45. Howe, SJ, Mansour, MR, Schwarzwaelder, K, Bartholomae, C, Hubank, M, Kempski, H et al. (2008). Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 118: 3143-3150.
46. Dull, T, Zufferey, R, Kelly, M, Mandel, RJ, Nguyen, M, Trono, D et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471.
47. Buckley, SM, Howe, SJ, Sheard, V, Ward, NJ, Coutelle, C, Thrasher, AJ et al. (2008). Lentiviral transduction of the murine lung provides effcient pseudotype and developmental stage-dependent cell-specifc transgene expression. Gene Ther 15: 1167-1175.
48. Johnson, LG, Mewshaw, JP, Ni, H, Friedmann, T, Boucher, RC and Olsen, JC (1998). Effect of host modifcation and age on airway epithelial gene transfer mediated by a murine leukemia virus-derived vector. J Virol 72: 8861-8872.
49. Demaison, C, Parsley, K, Brouns, G, Scherr, M, Battmer, K, Kinnon, C et al. (2002). High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodefciency [correction of imunodefciency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther 13: 803-813.
50. DiPersio, CM, Shah, S and Hynes, RO (1995). alpha 3A beta 1 integrin localizes to focal contacts in response to diverse extracellular matrix proteins. J Cell Sci 108 (Pt 6): 2321-2336.